Curant Health, a multifaceted Medication Care Management® organization, dedicated to the care of complex patients nationwide, is proud to announce the launch of our Curant Rare™ business unit. Curant Rare™ utilizes our complex care patient services and unmatched business intelligence capabilities within our award-winning specialty pharmacy platform to improve the clinical health outcomes of patients suffering from rare disease.
“Curant Rare™ is the result of 25 years of caring for patients suffering from complex diseases. Through 12 IRB approved clinical studies with the nation’s leading academic medical centers, we have consistently demonstrated Curant’s ability to improve health outcomes in this fragile population. This extensive experience makes Curant Rare™ uniquely qualified to help launch and support rare medications. Curant Rare™ is solely focused on providing best-in-class medication support services and comprehensive business intelligence insights to ensure success for our rare pharma customers in their commercialization efforts,” said Patrick Dunham, CEO and Co-Founder of Curant Health.
Curant Rare™ further highlights Curant Health's commitment to life-saving patient support and the empowerment of families navigating the challenges of rare diseases. Curant Health holds accreditations from URAC, ACHC and NABP as well as certification from HITRUST.
For more information, please visit www.curantrare.com.
About Curant Health
Curant Health provides boutique distribution and data solutions to optimize rare disease patient and partner journeys. Curant Health’s personalized approach to patient care focuses on rare and ultra-rare patient populations to improve outcomes in measurable and meaningful ways. Curant Health provides detailed and high-quality care while placing the patient's physical and psychosocial well-being as a priority. Curant Health enhances the rare disease patient journey, while supporting healthcare teams through their validated Medication Care Management® services. With over 20 years of experience, Curant Health brings a proven track record in:
- Increasing patient compliance and Quality of Life
- Providing additional resources for the management of rare disease patients
- Utilizing our MCM® process to generate Real World Evidence (RWE) and Real-World Data (RWD)
- Reporting on product suitability and unmet patient needs
- Reporting on adverse events, side effects or potential drug interactions
- Providing extra support and feedback to physicians and their teams on the patient journey
View source version on businesswire.com: https://www.businesswire.com/news/home/20250123320689/en/
Contacts
Culver Lyons
Sr. Manager, Field Marketing
clyons@curanthealth.com
